Xu XL,Fang Y,Lee TC,et al.Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2signaling[J].Cell,2009,137(6):1 018-1 031.
[2]
Munier FL,Gaillard MC,Stathopoulos C.Anterior chamber chemotherapy in retinoblastoma-necessary but not sufficient for aqueous seeding control[J].JAMAOphthalmol,2018,136(5):596-597.
[3]
郁想想,陈长征,赵军阳,等.视网膜母细胞瘤综合治疗疗效分析[J].武汉大学学报:医学版,2012,33(2):247-250.Yu XX,Chen CZ,Zhao JY,et al.Outcomes of combined modality therapy of retinoblastoma[J].Medical Journal of Wuhan University,2012,33(2):247-250.
[4]
赵桂秋,孙为荣.眼科病理学[M].第2版.北京:人民卫生出版社,2014:367-429.Zhao GQ,Sun WR.Ophthalmology Pathology[M].Second edition.Beijing:People's Health Publishing House,2014:367-429.
[5]
Adithi M,Nalini V,Kandalam M,et al.Retinoblastoma in the United States:A 40-year incidence and survival analysis[J].Journal of Pediatric Ophthalmology&Steabismus,2018,55(3):182-188.
[6]
Temming P,Arendt M,Viehmann A,et al.Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors:A report from the German reference center[J].Pediatr Blood Cancer,2017,64(1):71-80.